Liu et al. (2020) reported that melatonin highly regulates serum amino acid levels in mice with inflammatory bowel disease; moreover, melatonin can alleviate insulin resistance and obesity by activating the AMPKα/PPARα signaling pathway. This evidence concerns the gene PPARA and inflammatory bowel disease.